ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol (s) |
Name of each exchange on which registered | ||
☒ |
Accelerated filer |
☐ | ||||
Non-accelerated filer |
☐ |
Smaller reporting company |
||||
Emerging growth company |
Page |
||||||
4 |
||||||
17 |
||||||
31 |
||||||
31 |
||||||
31 |
||||||
32 |
||||||
33 |
||||||
34 |
||||||
35 |
||||||
52 |
||||||
53 |
||||||
53 |
||||||
53 |
||||||
54 |
||||||
55 |
||||||
56 |
||||||
56 |
||||||
57 |
||||||
57 |
||||||
58 |
||||||
60 |
||||||
61 |
• |
uncertainties relating to the continuing impact of the COVID-19 pandemic, including the length and severity of such pandemic and the federal government’s proposed stimulus response package, and the pace of recovery following such pandemic; |
• |
general uncertainty in the capital markets and a worsening of economic conditions and the rate and pace of economic recovery following an economic downturn; |
• |
changes in our business operations, including restrictions on business activities, resulting from the COVID-19 pandemic; |
• |
market trends in the commercial real estate market or the general economy; |
• |
our ability to attract and retain qualified senior executives, managers and investment sales and financing professionals; |
• |
the effects of increased competition on our business; |
• |
our ability to successfully enter new markets or increase our market share; |
• |
our ability to successfully expand our services and businesses and to manage any such expansions; |
• |
our ability to retain existing clients and develop new clients; |
• |
our ability to keep pace with changes in technology; |
• |
any business interruption or technology failure and any related impact on our reputation; |
• |
changes in interest rates, tax laws, employment laws or other government regulation affecting our business; |
• |
our ability to successfully identify, negotiate, execute and integrate accretive acquisitions; and |
• |
other risk factors included under “Risk Factors” in this Annual Report on Form 10-K. |
• |
a 50-year history of providing investment brokerage and financing services through proprietary inventory and marketing systems, policies and culture of information sharing and in-depth investment brokerage training. These services are executed by our salesforce under the supervision of a dedicated sales management team focused on client service and growing the firm; |
• |
market leading share and brand within the $1-$10 million private client market segment, which consistently represents more than 80% of total U.S. commercial property transactions greater than $1 million in the marketplace; |
• |
investment sales and financing professionals providing exclusive client representation across multiple property types; |
• |
a broad geographic platform in the United States and Canada powered by information sharing and proprietary real estate marketing technologies; |
• |
an ability to scale with our private clients as they grow and connect private capital with larger assets through our Institutional Property Advisors (“IPA”) division; |
• |
a financing team integrated with our brokerage sales force providing independent mortgage brokerage services by accessing a wide range of lenders on behalf of our clients; |
• |
a sales management team, who serves in a support and leadership role as company executives and who does not compete with or participate in investment sales professionals’ commissions; and |
• |
industry-leading research and advisory services tailored to the needs of our clients and supporting our investment sales and financing professionals. |
• |
Properties priced less than $1 million; |
• |
Private client market: |
• |
Middle market: |
• |
Larger transaction market: |
2020 |
2019 |
Change |
||||||||||||||||||||||||||||||||||
Real Estate Brokerage: |
Number |
Volume |
Revenues |
Number |
Volume |
Revenues |
Number |
Volume |
Revenues |
|||||||||||||||||||||||||||
(in millions) |
(in thousands) |
(in millions) |
(in thousands) |
(in millions) |
(in thousands) |
|||||||||||||||||||||||||||||||
<$1 million |
944 |
$ |
600 |
$ |
24,456 |
1,011 |
$ |
657 |
$ |
27,012 |
(67 |
) |
$ |
(57 |
) |
$ |
(2,556 |
) | ||||||||||||||||||
Private client market ($1 - <$10 million) |
4,773 |
15,115 |
421,767 |
5,311 |
17,239 |
487,528 |
(538 |
) |
(2,124 |
) |
(65,761 |
) | ||||||||||||||||||||||||
Middle market ($10 - <$20 million) |
316 |
4,311 |
81,621 |
441 |
6,002 |
107,818 |
(125 |
) |
(1,691 |
) |
(26,197 |
) | ||||||||||||||||||||||||
Larger transaction market ( ³ $20 million) |
255 |
12,026 |
105,320 |
279 |
12,960 |
106,998 |
(24 |
) |
(934 |
) |
(1,678 |
) | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
6,288 |
$ |
32,052 |
$ |
633,164 |
7,042 |
$ |
36,858 |
$ |
729,356 |
(754 |
) |
$ |
(4,806 |
) |
$ |
(96,192 |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
• |
Any impairment in value of our investments in marketable debt securities, available-for-sale |
• |
A potential negative impact on the health of our employees and investment sales and financing professionals, particularly if a significant number of them are impacted, could result in a deterioration in our ability to ensure business continuity during a disruption. |
• |
If significant portions of our workforce are unable to work effectively, including because of quarantines, facility closures, ineffective remote work arrangements or technology failures or limitations, our operations would be adversely impacted. |
• |
If we need to raise additional capital through public or private debt or equity financings, strategic relationships or other arrangements, this capital might not be available to us in a timely manner, on acceptable terms, or at all due to various risks and uncertainties. Our failure to raise sufficient capital when needed could prevent us from funding acquisitions or otherwise financing our growth or operations. If we are not able to respond to and manage the impact of such events effectively, our business will be harmed. |
Base Period 12/31/15 |
12/31/16 |
12/31/17 |
12/31/18 |
12/31/19 |
12/31/20 |
|||||||||||||||||||
Marcus & Millichap, Inc. |
100.00 |
91.70 |
111.91 |
117.81 |
127.83 |
127.76 |
||||||||||||||||||
S&P 500 Index |
100.00 |
111.96 |
136.40 |
130.42 |
171.49 |
203.04 |
||||||||||||||||||
Peer Group (2020) |
100.00 |
80.38 |
111.50 |
96.61 |
142.94 |
132.71 |
||||||||||||||||||
Peer Group (2019) |
100.00 |
81.78 |
116.85 |
103.60 |
153.60 |
149.07 |
Years Ended December 31, |
||||||||||||||||||||
2020 |
2019 |
2018 |
2017 |
2016 |
||||||||||||||||
(in thousands except per share, investment sales and financing professional and sales volume amounts) |
||||||||||||||||||||
Statement of Income Data: |
||||||||||||||||||||
Total revenues |
$ |
716,906 |
$ |
806,428 |
$ |
814,816 |
$ |
719,700 |
$ |
717,450 |
||||||||||
Cost of services |
447,879 |
498,878 |
502,883 |
446,557 |
444,768 |
|||||||||||||||
Operating income |
53,614 |
96,423 |
112,287 |
96,132 |
106,501 |
|||||||||||||||
Provision for income taxes (1) |
16,526 |
30,582 |
29,963 |
47,702 |
42,445 |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income |
$ |
42,838 |
$ |
76,930 |
$ |
87,257 |
$ |
51,524 |
$ |
64,657 |
||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Earnings per share: |
||||||||||||||||||||
Basic |
$ |
1.08 |
$ |
1.95 |
$ |
2.23 |
$ |
1.32 |
$ |
1.66 |
||||||||||
Diluted |
$ |
1.08 |
$ |
1.95 |
$ |
2.22 |
$ |
1.32 |
$ |
1.66 |
||||||||||
Weighted average common shares outstanding: |
||||||||||||||||||||
Basic |
39,642 |
39,404 |
39,149 |
38,988 |
38,899 |
|||||||||||||||
Diluted |
39,735 |
39,548 |
39,383 |
39,100 |
39,035 |
|||||||||||||||
Balance Sheet Data: |
||||||||||||||||||||
Cash and cash equivalents |
$ |
243,152 |
$ |
232,670 |
$ |
214,683 |
$ |
220,786 |
$ |
187,371 |
||||||||||
Marketable debt securities, available-for-sale (2) |
$ |
206,031 |
$ |
211,561 |
$ |
220,645 |
$ |
125,659 |
$ |
104,929 |
||||||||||
Total assets |
$ |
779,122 |
$ |
709,034 |
$ |
566,380 |
$ |
459,664 |
$ |
394,016 |
||||||||||
Long-term liabilities |
$ |
111,969 |
$ |
112,322 |
$ |
63,950 |
$ |
61,517 |
$ |
56,986 |
||||||||||
Total liabilities |
$ |
232,286 |
$ |
214,127 |
$ |
156,806 |
$ |
144,776 |
$ |
135,162 |
||||||||||
Total stockholders’ equity |
$ |
546,836 |
$ |
494,907 |
$ |
409,574 |
$ |
314,888 |
$ |
258,854 |
||||||||||
Other Data: |
||||||||||||||||||||
Adjusted EBITDA (3) |
$ |
75,699 |
$ |
115,551 |
$ |
129,457 |
$ |
111,716 |
$ |
118,296 |
||||||||||
Investment sales and financing professionals |
2,097 |
2,021 |
1,977 |
1,819 |
1,737 |
|||||||||||||||
Sales volume (dollars in millions) |
$ |
43,407 |
$ |
49,706 |
$ |
46,355 |
$ |
42,191 |
$ |
42,312 |
(1) |
Provision for income taxes for 2017 includes a one-time charge in the amount of $11.6 million in connection with the remeasurement of deferred tax assets, net due to enactment of the Tax Cuts and Jobs Act, which reduced the U.S. federal statutory corporate tax rate from 35% to 21% starting in 2018. In addition, we adopted Accounting Standards Update No. 2016-09, Improvements to Employee Share-Based Payment Accounting non-employee directors’ vesting of equity awards granted under our Amended and Restated 2013 Omnibus Equity Incentive Plan. Prior to 2017, windfalls tax benefits, net were recorded directly to additional paid in capital. |
(2) |
Includes both short-term and long-term marketable debt securities, available-for-sale. |
(3) |
Adjusted EBITDA is not a measurement of our financial performance under U.S. generally accepted accounting principles (“U.S. GAAP”) and should not be considered as an alternative to net income, operating income or any other measures derived in accordance with U.S. GAAP. For a definition of Adjusted EBITDA and a reconciliation of Adjusted EBITDA to net income, see Item 7 – “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Non-GAAP Financial Measure.” |
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Real Estate Brokerage: |
||||||||||||
Average Number of Investment Sales Professionals |
1,920 |
1,843 |
1,726 |
|||||||||
Average Number of Transactions per Investment Sales Professional |
3.28 |
3.82 |
4.10 |
|||||||||
Average Commission per Transaction |
$ |
100,694 |
$ |
103,572 |
$ |
105,574 |
||||||
Average Commission Rate |
1.98 |
% |
1.98 |
% |
2.07 |
% | ||||||
Average Transaction Size (in thousands) |
$ |
5,097 |
$ |
5,234 |
$ |
5,095 |
||||||
Total Number of Transactions |
6,288 |
7,042 |
7,079 |
|||||||||
Total Sales Volume (in millions) |
$ |
32,052 |
$ |
36,858 |
$ |
36,070 |
||||||
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Financing (1) : |
||||||||||||
Average Number of Financing Professionals |
86 |
102 |
100 |
|||||||||
Average Number of Transactions per Financing Professional |
22.59 |
19.06 |
16.78 |
|||||||||
Average Fee per Transaction |
$ |
33,747 |
$ |
32,680 |
$ |
33,176 |
||||||
Average Fee Rate |
0.85 |
% |
0.88 |
% |
0.89 |
% | ||||||
Average Transaction Size (in thousands) |
$ |
3,948 |
$ |
3,693 |
$ |
3,716 |
||||||
Total Number of Transactions |
1,943 |
1,944 |
1,678 |
|||||||||
Total Financing Volume (in millions) |
$ |
7,672 |
$ |
7,180 |
$ |
6,236 |
(1) |
Operating metrics calculated excluding certain financing fees not directly associated to transactions. |
Year Ended December 31, 2020 |
Percentage of Revenue |
Year Ended December 31, 2019 |
Percentage of Revenue |
Change |
||||||||||||||||||||
Dollar |
Percentage |
|||||||||||||||||||||||
Revenues: |
||||||||||||||||||||||||
Real estate brokerage commissions |
$ |
633,164 |
88.3 |
% |
$ |
729,356 |
90.4 |
% |
$ |
(96,192 |
) |
(13.2 |
)% | |||||||||||
Financing fees |
70,538 |
9.8 |
66,293 |
8.2 |
4,245 |
6.4 |
% | |||||||||||||||||
Other revenues |
13,204 |
1.9 |
10,779 |
1.4 |
2,425 |
22.5 |
% | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total revenues |
716,906 |
100.0 |
806,428 |
100.0 |
(89,522 |
) |
(11.1 |
)% | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Operating expenses: |
||||||||||||||||||||||||
Cost of services |
447,879 |
62.5 |
498,878 |
61.9 |
(50,999 |
) |
(10.2 |
)% | ||||||||||||||||
Selling, general and administrative |
204,514 |
28.5 |
203,110 |
25.1 |
1,404 |
0.7 |
% | |||||||||||||||||
Depreciation and amortization |
10,899 |
1.5 |
8,017 |
1.0 |
2,882 |
35.9 |
% | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total operating expenses |
663,292 |
92.5 |
710,005 |
88.0 |
(46,713 |
) |
(6.6 |
)% | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Operating income |
53,614 |
7.5 |
96,423 |
12.0 |
(42,809 |
) |
(44.4 |
)% | ||||||||||||||||
Other income (expense), net |
6,650 |
0.9 |
12,477 |
1.5 |
(5,827 |
) |
(46.7 |
)% | ||||||||||||||||
Interest expense |
(900 |
) |
(0.1 |
) |
(1,388 |
) |
(0.2 |
) |
488 |
(35.2 |
)% | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Income before provision for income taxes |
59,364 |
8.3 |
107,512 |
13.3 |
(48,148 |
) |
(44.8 |
)% | ||||||||||||||||
Provision for income taxes |
16,526 |
2.3 |
30,582 |
3.8 |
(14,056 |
) |
(46.0 |
)% | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net income |
$ |
42,838 |
6.0 |
% |
$ |
76,930 |
9.5 |
% |
$ |
(34,092 |
) |
(44.3 |
)% | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Adjusted EBITDA (1) |
$ |
75,699 |
10.6 |
% |
$ |
115,551 |
14.3 |
% |
$ |
(39,852 |
) |
(34.5 |
)% | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Adjusted EBITDA is not a measurement of our financial performance under U.S. generally accepted accounting principles (“U.S. GAAP”) and should not be considered as an alternative to net income, operating income or any other measures derived in accordance with U.S. GAAP. For a definition of Adjusted EBITDA and a reconciliation of Adjusted EBITDA to net income, see “Non-GAAP Financial Measure.” |
Years Ended December 31, |
||||||||||||||||||||
2020 |
2019 |
2018 |
2017 |
2016 |
||||||||||||||||
Net income |
$ |
42,838 |
$ |
76,930 |
$ |
87,257 |
$ |
51,524 |
$ |
64,657 |
||||||||||
Adjustments: |
||||||||||||||||||||
Interest income and other (1) |
(5,048 |
) |
(10,322 |
) |
(7,052 |
) |
(3,514 |
) |
(1,761 |
) | ||||||||||
Interest expense |
900 |
1,388 |
1,400 |
1,496 |
1,533 |
|||||||||||||||
Provision for income taxes (2) |
16,526 |
30,582 |
29,963 |
47,702 |
42,445 |
|||||||||||||||
Depreciation and amortization |
10,899 |
8,017 |
6,297 |
5,363 |
4,387 |
|||||||||||||||
Stock-based compensation |
9,905 |
9,278 |
11,983 |
9,145 |
7,035 |
|||||||||||||||
Non-cash MSR activity (3) |
(321 |
) |
(322 |
) |
(391 |
) |
— |
— |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjusted EBITDA (4) |
$ |
75,699 |
$ |
115,551 |
$ |
129,457 |
$ |
111,716 |
$ |
118,296 |
||||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
Other includes net realized gains (losses) on marketable debt securities available-for-sale. |
(2) |
The year ended December 31, 2017, includes a one-time charge in the amount of $11.6 million in connection with the remeasurement of deferred tax assets, net due to enactment of Tax Cuts and Jobs Act, which reduced the U.S. federal statutory corporate tax rate from 35% to 21% starting in 2018. In addition, we adopted a new accounting pronouncement in 2017 that required any windfall tax benefits, net of shortfalls to be recorded as a discrete item in our provision for income taxes. Prior to 2017, windfalls tax benefits, net were recorded directly to additional paid in capital. These windfalls/shortfalls arise from the difference in the grant date price and the vesting date price of employee and non-employee directors vesting of equity awards granted under our 2013 Plan. |
(3) |
Non-cash MSR activity includes the assumption of servicing obligations. |
(4) |
The decrease in Adjusted EBITDA for the year ended December 31, 2020 compared to the same period in 2019 is primarily due to a decrease in total revenues and a higher proportion of operating expenses compared to total revenues. |
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Net cash provided by operating activities |
$ |
38,088 |
$ |
25,287 |
$ |
117,314 |
||||||
Net cash used in investing activities |
(17,228 |
) |
(3,422 |
) |
(117,980 |
) | ||||||
Net cash used in financing activities |
(10,330 |
) |
(3,878 |
) |
(5,437 |
) | ||||||
Effect of currency exchange rate changes on cash and cash equivalents |
(48 |
) |
— |
— |
||||||||
|
|
|
|
|
|
|||||||
Net increase (decrease) in cash and cash equivalents |
10,482 |
17,987 |
(6,103 |
) | ||||||||
Cash and cash equivalents at beginning of year |
232,670 |
214,683 |
220,786 |
|||||||||
|
|
|
|
|
|
|||||||
Cash and cash equivalents at end of year |
$ |
243,152 |
$ |
232,670 |
$ |
214,683 |
||||||
|
|
|
|
|
|
Total |
Less than 1 Year |
1-3 Years |
3-5 Years |
More Than 5 Years |
Other (7) |
|||||||||||||||||||
Operating lease liabilities, including imputed interest (1) |
$ |
84,523 |
$ |
22,970 |
$ |
31,413 |
$ |
20,938 |
$ |
9,202 |
$ |
— | ||||||||||||
SARs liability (principal and interest) (2) |
22,356 |
2,162 |
4,515 |
4,896 |
10,783 |
— |
||||||||||||||||||
Deferred commissions payable (3) |
34,592 |
19,286 |
15,306 |
— |
— |
— |
||||||||||||||||||
Deferred compensation liability (4) |
8,287 |
1,519 |
1,026 |
127 |
— |
5,615 |
||||||||||||||||||
Contingent consideration (5) |
5,572 |
1,353 |
2,277 |
1,573 |
369 |
— |
||||||||||||||||||
Deferred consideration (5) |
15,248 |
6,666 |
6,998 |
1,584 |
— |
— |
||||||||||||||||||
Other (6) |
21,230 |
12,511 |
2,331 |
880 |
440 |
5,068 |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$ |
191,808 |
$ |
66,467 |
$ |
63,866 |
$ |
29,998 |
$ |
20,794 |
$ |
10,683 |
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
See Note 4 – “Operating Leases” of our Notes to the Consolidated Financial Statements. |
(2) |
Forecasted principal payments are based on each participant’s estimated retirement age and contractual interest rate of 2.930% on January 1, 2021 and reflect required payments that result from the retirement of certain executives. See Note 7 – “Selected Balance Sheet Data” of our Notes to the Consolidated Financial Statements. |
(3) |
Includes short-term and long-term deferred commissions payable. See Note 7 – “Selected Balance Sheet Data” of our Notes to the Consolidated Financial Statements. |
(4) |
Represents current estimated payouts for participants currently receiving payments based on their elections at the time of deferral. We hold assets held in rabbi trust of $10.3 million to settle outstanding amounts when they become due. Amounts assume no increase in asset or liability due to future returns. |
(5) |
Relates to contingent and deferred consideration in connection with our business acquisitions. See Note 6 – “Acquisitions, Goodwill and Other Intangible Assets” and Note 10 – “Fair Value Measurements” of our Notes to the Consolidated Financial Statements. |
(6) |
Relates to amounts that may be advanced to sales and financing professionals and uncertain tax positions. See Note 13 – “Income Taxes” and Note 16 – “Commitments and Contingencies” of our Notes to the Consolidated Financial Statements. |
(7) |
Amounts in Other represent amounts where payments are dependent on future events, which may occur at any time from less than 1 year to more than 5 years and relates to our deferred compensation liability and uncertain tax positions. Payments for deferred compensation liability are based on the participants’ elections at the time of deferral. The net liability for uncertain tax positions may be payable by us in the future. The ultimate resolution depends on many factors and assumptions; accordingly, we are not able to reasonably estimate the timing of such payments, if any. |
Change in Interest Rates |
Approximate Change in Fair Value of Investments Increase (Decrease) |
|||
|
|
|
|
|
2% Decrease |
$ |
1,873 |
||
1% Decrease |
$ |
1,368 |
||
1% Increase |
$ |
(2,103 |
) | |
2% Increase |
$ |
(4,205 |
) |
Name |
Age |
Position(s) | ||||
Hessam Nadji |
55 |
President, Chief Executive Officer and Director | ||||
Steven F. DeGennaro |
57 |
Executive Vice President and Chief Financial Officer | ||||
Gregory A. LaBerge |
50 |
Senior Vice President, Chief Administrative Officer | ||||
Martin E. Louie |
59 |
Senior Vice President, Corporate Initiatives |
• |
From our main web page, click on “Investor Relations” at the bottom of the main web page. |
• |
Next click on “Corporate Governance” in the middle navigation bar. |
• |
Then click on “Governance Documents.” |
• |
Finally, click on “Code of Ethics.” |
Plan Category |
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights (1) |
Weighted- Average Exercise Price of Outstanding Options, Warrants and Rights (2) |
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) (3) (4) |
|||||||||
(a) |
(b) |
(c) |
||||||||||
Equity compensation plans approved by security holders |
1,243,217 |
$ |
— |
5,092,371 |
||||||||
Equity compensation plans not approved by security holders |
— |
— |
— |
|||||||||
|
|
|
|
|
|
|||||||
1,243,217 |
$ |
— |
5,092,371 |
|||||||||
|
|
|
|
|
|
(1) |
Consists of deferred stock units (“DSUs”) and restricted stock units (“RSUs”) granted under our Amended and Restated 2013 Omnibus Equity Incentive Plan (“2013 Plan”). Excludes restricted stock awards granted under the 2013 Plan, purchase rights granted under our 2013 Employee Stock Purchase Plan (“ESPP”) and cash settled SARs. |
(2) |
Outstanding DSUs and RSUs have no exercise price. |
(3) |
Includes 4,915,494 shares available for future issuance under the 2013 Plan. Includes 176,877 shares available for future issuance under the ESPP, including shares subject to purchase during the current offering period, which commenced on November 15, 2020 (the exact number of which will not be known until the purchase date on May 15, 2021). Subject to the number of shares remaining in the share reserve, the maximum number of shares purchasable by any participant on any one purchase date for any purchase period, including the current purchase period may not exceed 1,250 shares. |
(4) |
Pursuant to the terms of the ESPP, on the first day of each fiscal year, beginning with the 2015 fiscal year, the number of shares authorized for issuance under the ESPP is automatically increased by the lesser of: (i) 366,667 shares of our common stock; (ii) 1% of the outstanding shares of our common stock as of the last day of the immediately preceding fiscal year; or (iii) such other amount as the Board may determine. Pursuant to the provisions of the ESPP, the Board has determined to not provide for any annual increases to date. |
(a) |
The following documents are filed as part of this Report: |
(1) |
Consolidated Financial Statements |
(2) |
Financial Statement Schedules |
(b) |
Exhibits |
Number |
Description | |
3.1 |
||
3.2 |
||
4.1 |
||
4.2 |
||
10.1 |
||
10.2† |
||
10.3† |
Number |
Description | |
10.4† |
||
10.5† |
||
10.6† |
||
10.7† |
||
10.8† |
||
10.9† |
||
10.10† |
||
10.11† |
||
10.12† |
||
10.13 |
||
10.14 |
||
10.15 |
||
10.16† |
||
10.17* |
||
21.1* |
||
23.1* |
||
31.1* |
Number |
Description | |
31.2* |
||
32.1** |
||
101* |
The following financial statements from the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, formatted in Inline XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Net and Comprehensive Income, (iii) Consolidated Statements of Stockholders’ Equity, (iv) Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags. | |
104* |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
† |
Indicates management contract or compensatory plan. |
* |
Filed herewith. |
** |
Furnished, not filed. |
(c) |
Financial Statement Schedules |
Dated: March 1, 2021 |
Marcus & Millichap, Inc | |||||
/s/ Hessam Nadji | ||||||
Hessam Nadji | ||||||
President and Chief Executive Officer |
Signature |
Title |
Date | ||
/s/ Hessam Nadji Hessam Nadji |
Director, President and Chief Executive Officer (Principal Executive Officer) |
March 1, 2021 | ||
/s/ Steven F. DeGennaro Steven F. DeGennaro |
Chief Financial Officer (Principal Financial Officer) |
March 1, 2021 | ||
/s/ Kurt H. Schwarz Kurt H. Schwarz |
First Vice President of Finance and Chief Accounting Officer (Principal Accounting Officer) |
March 1, 2021 | ||
/s/ George M. Marcus George M. Marcus |
Director |
March 1, 2021 | ||
/s/ Norma J. Lawrence Norma J. Lawrence |
Director |
March 1, 2021 | ||
/s/ Lauralee E. Martin Lauralee E. Martin |
Director |
March 1, 2021 | ||
/s/ Nicholas F. McClanahan Nicholas F. McClanahan |
Director |
March 1, 2021 | ||
/s/ George T. Shaheen George T. Shaheen |
Director |
March 1, 2021 | ||
/s/ Don C. Watters Don C. Watters |
Director |
March 1, 2021 |
Page |
||||
F-2 |
||||
F-6 |
||||
F-7 |
||||
F-8 |
||||
F-9 |
||||
F-10 |
Description of the Matter |
At December 31, 2020, the Company’s commissions payable to investment sales and financing professionals was $69.4 million. As discussed in Note 7 to the consolidated financial statements, certain investment sales and financing professionals have the ability to earn additional commissions after meeting certain annual revenue thresholds. All commissions are recognized as cost of services in the period in which they are earned as they relate to specific transactions closed. The Company has the ability to defer payment of certain commissions, at its election, for up to three years. These payments are referred to as deferred commissions. Auditing the Company’s deferred commissions was complex with regard to evaluating the completeness of the population of investment sales and financing professionals eligible for deferred commissions and the accuracy of the investment sales and financing professionals’ revenue thresholds used in determining deferred commissions earned. |
How We Addressed the Matter in Our Audit |
We evaluated the design and tested the operating effectiveness of the Company’s internal controls over the deferred commissions process. For example, we tested controls over the completeness and accuracy of the data used in calculating the deferred commissions, including approvals. To test the deferred commissions payable, we performed audit procedures that included, among others, performing a predictive test in which we evaluated the completeness of the deferred commissions schedule based on investment sales and financing professionals’ sales performance. Additionally, we performed procedures to obtain evidence of eligibility approval and performed a hindsight analysis to evaluate the amount of cash disbursed to the amount of deferred commissions payable previously accrued. |
December 31, |
||||||||
2020 |
2019 |
|||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ |
$ |
||||||
Commissions receivable, net |
||||||||
Prepaid expenses |
||||||||
Income tax receivable |
||||||||
Marketable debt securities, available-for-sale |
||||||||
Advances and loans, net |
||||||||
Other assets |
||||||||
Total current assets |
||||||||
Property and equipment, net |
||||||||
Operating lease right-of-use |
||||||||
Marketable debt securities, available-for-sale |
||||||||
Assets held in rabbi trust |
||||||||
Deferred tax assets, net |
||||||||
Goodwill and other intangible assets, net |
||||||||
Advances and loans, net |
||||||||
Other assets |
||||||||
Total assets |
$ |
$ |
||||||
Liabilities and stockholders’ equity |
||||||||
Current liabilities: |
||||||||
Accounts payable and other liabilities |
$ |
$ |
||||||
Notes payable to former stockholders |
||||||||
Deferred compensation and commissions |
||||||||
Income tax payable |
||||||||
Operating lease liabilities |
||||||||
Accrued bonuses and other employee related expenses |
||||||||
Total current liabilities |
||||||||
Deferred compensation and commissions |
||||||||
Operating lease liabilities |
||||||||
Other liabilities |
||||||||
Total liabilities |
||||||||
Commitments and contingencies |
||||||||
Stockholders’ equity: |
||||||||
Preferred stock, $ |
||||||||
Authorized shares – |
||||||||
Common stock, $ |
||||||||
Authorized shares – |
||||||||
Additional paid-in capital |
||||||||
Stock notes receivable from employees |
( |
) | ||||||
Retained earnings |
||||||||
Accumulated other comprehensive income |
||||||||
Total stockholders’ equity |
||||||||
Total liabilities and stockholders’ equity |
$ |
$ |
||||||
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Revenues: |
||||||||||||
Real estate brokerage commissions |
$ | $ | $ | |||||||||
Financing fees |
||||||||||||
Other revenues |
||||||||||||
|
|
|
|
|
|
|||||||
Total revenues |
||||||||||||
|
|
|
|
|
|
|||||||
Operating expenses: |
||||||||||||
Cost of services |
||||||||||||
Selling, general and administrative |
||||||||||||
Depreciation and amortization |
||||||||||||
|
|
|
|
|
|
|||||||
Total operating expenses |
||||||||||||
|
|
|
|
|
|
|||||||
Operating income |
||||||||||||
Other income (expense), net |
||||||||||||
Interest expense |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Income before provision for income taxes |
||||||||||||
Provision for income taxes |
||||||||||||
|
|
|
|
|
|
|||||||
Net income |
||||||||||||
|
|
|
|
|
|
|||||||
Other comprehensive income (loss): |
||||||||||||
Marketable debt securities, available-for-sale: |
||||||||||||
Change in net unrealized gains (losses) |
( |
) | ||||||||||
Less: reclassification adjustment for net losses (gains) included in other income (expense), net |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net change, net of tax of $ |
( |
) | ||||||||||
Foreign currency translation (loss) gain, net of tax of $ |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Total other comprehensive income (loss) |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Comprehensive income |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Earnings per share: |
||||||||||||
Basic |
$ | $ | $ | |||||||||
Diluted |
$ | $ | $ | |||||||||
Weighted average common shares outstanding: |
||||||||||||
Basic |
||||||||||||
Diluted |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Series A Redeemable Preferred Stock |
Common Stock |
Additional Paid-In Capital |
Stock Notes Receivable From Employees |
Retained Earnings |
Accumulated Other Comprehensive Income (Loss) |
Total |
||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||
Balance as of December 31, 2017 |
$ | $ | $ | $ | ( |
) | $ | $ | $ | |||||||||||||||||||||||||||
Cumulative effect of a change in accounting principle, net of tax |
( |
) | ||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance at January 1, 2018, as adjusted |
( |
) | ||||||||||||||||||||||||||||||||||
Net and comprehensive income (loss) |
— | — | ( |
) | ||||||||||||||||||||||||||||||||
Stock-based award activity: |
||||||||||||||||||||||||||||||||||||
Stock-based compensation |
||||||||||||||||||||||||||||||||||||
Issuance of common stock pursuant to employee stock purchase plan |
||||||||||||||||||||||||||||||||||||
Issuance of common stock for settlement of deferred stock units |
||||||||||||||||||||||||||||||||||||
Issuance of common stock for vesting of restricted stock units |
||||||||||||||||||||||||||||||||||||
Issuance of common stock for unvested restricted stock awards |
||||||||||||||||||||||||||||||||||||
Shares withheld related to net share settlement of stock-based awards |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance as of December 31, 2018 |
( |
) | ||||||||||||||||||||||||||||||||||
Net and comprehensive income |
— | — | ||||||||||||||||||||||||||||||||||
Stock-based award activity: |
||||||||||||||||||||||||||||||||||||
Stock-based compensation |
||||||||||||||||||||||||||||||||||||
Issuance of common stock pursuant to employee stock purchase plan |
||||||||||||||||||||||||||||||||||||
Issuance of common stock for vesting of restricted stock units |
||||||||||||||||||||||||||||||||||||
Issuance of common stock for unvested restricted stock awards |
||||||||||||||||||||||||||||||||||||
Shares withheld related to net share settlement of stock-based awards |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance as of December 31, 2019 |
( |
) | ||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Cumulative effect of a change in accounting principle, net of tax |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance at January 1, 2020, as adjusted |
( |
) | ||||||||||||||||||||||||||||||||||
Net and comprehensive income |
— | — | ||||||||||||||||||||||||||||||||||
Stock-based award activity: |
||||||||||||||||||||||||||||||||||||
Stock-based compensation |
||||||||||||||||||||||||||||||||||||
Issuance of common stock pursuant to employee stock purchase plan |
||||||||||||||||||||||||||||||||||||
Issuance of common stock for vesting of restricted stock units |
||||||||||||||||||||||||||||||||||||
Issuance of common stock for unvested restricted stock awards |
||||||||||||||||||||||||||||||||||||
Shares withheld related to net share settlement of stock-based awards |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Reduction of stock notes receivable from employees |
— | — | ||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance as of December 31, 2020 |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Cash flows from operating activities |
||||||||||||
Net income |
$ |
$ |
$ |
|||||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||||||
Depreciation and amortization |
||||||||||||
Amortization of right-of-use |
||||||||||||
Credit loss expense |
||||||||||||
Stock-based compensation |
||||||||||||
Deferred taxes, net |
( |
) | ||||||||||
Unrealized foreign exchange gain |
( |
) |
||||||||||
Net realized gains on marketable debt securities, available-for-sale |
( |
) |
( |
) |
( |
) | ||||||
Other non-cash items |
( |
) |
( |
) | ||||||||
Changes in operating assets and liabilities: |
||||||||||||
Commissions receivable |
( |
) |
( |
) |
||||||||
Prepaid expenses |
( |
) |
||||||||||
Advances and loans |
( |
) |
( |
) |
( |
) | ||||||
Prepaid rent |
||||||||||||
Other assets |
( |
) |
( |
) |
( |
) | ||||||
Accounts payable and other liabilities |
( |
) |
||||||||||
Income tax receivable/payable |
( |
) |
||||||||||
Accrued bonuses and other employee related expenses |
( |
) |
( |
) |
||||||||
Deferred compensation and commissions |
( |
) |
( |
) | ||||||||
Operating lease liabilities |
( |
) |
( |
) |
||||||||
Other liabilities |
( |
) |
( |
) |
||||||||
Net cash provided by operating activities |
||||||||||||
Cash flows from investing activities |
||||||||||||
Acquisition of businesses, net of cash received |
( |
) |
( |
) |
( |
) | ||||||
Purchases of marketable debt securities, available-for-sale |
( |
) |
( |
) |
( |
) | ||||||
Proceeds from sales and maturities of marketable debt securities, available-for-sale |
||||||||||||
Issuances of employee notes receivable |
( |
) |
( |
) |
( |
) | ||||||
Payments received on employee notes receivable |
||||||||||||
Purchase of property and equipment |
( |
) |
( |
) |
( |
) | ||||||
Proceeds from sale of property and equipment |
||||||||||||
Net cash used in investing activities |
( |
) |
( |
) |
( |
) | ||||||
Cash flows from financing activities |
||||||||||||
Taxes paid related to net share settlement of stock-based awards |
( |
) |
( |
) |
( |
) | ||||||
Proceeds from issuance of shares pursuant to employee stock purchase plan |
||||||||||||
Principal payments on notes payable to former stockholders |
( |
) |
( |
) |
( |
) | ||||||
Principal payments on stock appreciation rights liability |
( |
) |
( |
) |
||||||||
Payments of contingent and deferred consideration |
( |
) |
( |
) |
||||||||
Net cash used in financing activities |
( |
) |
( |
) |
( |
) | ||||||
Effect of currency exchange rate changes on cash and cash equivalents |
( |
) |
||||||||||
Net increase (decrease) in cash and cash equivalents |
( |
) | ||||||||||
Cash and cash equivalents at beginning of year |
||||||||||||
Cash and cash equivalents at end of year |
$ |
$ |
$ |
|||||||||
Supplemental disclosures of cash flow information |
||||||||||||
Interest paid during the period |
$ |
$ |
$ |
|||||||||
Income taxes paid, net |
$ |
$ |
$ |
|||||||||
1. |
Description of Business and Basis of Presentation |
2. |
Accounting Policies and Recent Accounting Pronouncements |
• | Level 1: |
• | Level 2: |
• | Level 3: |
3. |
Property and Equipment, Net |
December 31, |
||||||||
2020 |
2019 |
|||||||
Computer software and hardware equipment |
$ | $ | ||||||
Furniture, fixtures and equipment |
||||||||
Less: accumulated depreciation and amortization |
( |
) | ( |
) | ||||
|
|
|
|
|||||
$ | $ | |||||||
|
|
|
|
4. |
Operating Leases |
Years Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Operating lease cost: |
||||||||
Lease cost (1) |
$ | $ | ||||||
Variable lease cost (2) |
||||||||
Sublease income |
( |
) | ( |
) | ||||
|
|
|
|
|||||
$ | $ | |||||||
|
|
|
|
(1) |
Includes short-term lease cost and ROU asset amortization. |
(2) |
Primarily relates to common area maintenance, property taxes, insurance, utilities and parking. |
December 31, 2020 |
||||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
|
|
|||
Total future minimum lease payments |
||||
Less imputed interest |
( |
) | ||
|
|
|||
Present value of operating lease liabilities |
$ | |||
|
|
Years Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Operating cash flow information: |
||||||||
Cash paid for amounts included in the measurement of operating lease liabilities |
$ | $ | ||||||
Noncash activity: |
||||||||
ROU assets obtained in exchange for operating lease liabilities |
$ | $ | ||||||
Tenant improvements owned by lessor related to ROU assets (1) |
$ | $ |
(1) |
Reclassification from other assets current. |
December 31, |
||||||||
2020 |
2019 |
|||||||
Weighted average remaining operating lease term |
||||||||
Weighted average discount rate |
% | % |
5. |
Investments in Marketable Debt Securities |
December 31, 2020 |
||||||||||||||||||||
Amortized Cost |
Allowance for Credit Losses |
Gross Unrealized Gains |
Gross Unrealized Losses |
Fair Value |
||||||||||||||||
Short-term investments: |
||||||||||||||||||||
U.S. treasuries |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||
U.S. government sponsored entities |
||||||||||||||||||||
Corporate debt |
( |
) | ||||||||||||||||||
$ | $ | $ | $ | ( |
) | $ | ||||||||||||||
Long-term investments: |
||||||||||||||||||||
U.S. treasuries |
$ | $ | $ | $ | $ | |||||||||||||||
U.S. government sponsored entities |
||||||||||||||||||||
Corporate debt |
( |
) | ||||||||||||||||||
ABS and other |
( |
) | ||||||||||||||||||
$ | $ | $ | $ | ( |
) | $ | ||||||||||||||
December 31, 2019 |
||||||||||||||||
Amortized Cost |
Gross Unrealized Gains |
Gross Unrealized Losses |
Fair Value |
|||||||||||||
Short-term investments: |
||||||||||||||||
U.S. treasuries |
$ | $ | $ | ( |
) | $ | ||||||||||
Corporate debt |
||||||||||||||||
$ | $ | $ | ( |
) | $ | |||||||||||
Long-term investments: |
||||||||||||||||
U.S. treasuries |
$ | $ | $ | $ | ||||||||||||
U.S. government sponsored entities |
( |
) | ||||||||||||||
Corporate debt |
( |
) | ||||||||||||||
ABS and other |
( |
) | ||||||||||||||
$ | $ | $ | ( |
) | $ | |||||||||||
December 31, 2020 |
||||||||||||||||||||||||
Less than 12 months |
12 months or greater |
Total |
||||||||||||||||||||||
Fair Value |
Gross Unrealized Losses |
Fair Value |
Gross Unrealized Losses |
Fair Value |
Gross Unrealized Losses |
|||||||||||||||||||
U.S. treasuries |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||
Corporate debt |
( |
) | ( |
) | ||||||||||||||||||||
ABS and other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | |||||||||||||
December 31, 2019 |
||||||||||||||||||||||||
Less than 12 months |
12 months or greater |
Total |
||||||||||||||||||||||
Fair Value |
Gross Unrealized Losses |
Fair Value |
Gross Unrealized Losses |
Fair Value |
Gross Unrealized Losses |
|||||||||||||||||||
U.S. treasuries |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||
U.S. government sponsored entities |
( |
) | ( |
) | ||||||||||||||||||||
Corporate debt |
( |
) | ( |
) | ||||||||||||||||||||
ABS and other |
( |
) | ( |
) | ||||||||||||||||||||
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | |||||||||||||
Years Ended |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Gross realized gains (1) |
$ | $ | $ | |||||||||
Gross realized losses (1) |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
(1) |
Recorded in other income (expense), net in the consolidated statements of net and comprehensive income. The cost basis of securities sold were determined based on the specific identification method. |
December 31, 2020 |
December 31, 2019 |
|||||||||||||||
Amortized Cost |
Fair Value |
Amortized Cost |
Fair Value |
|||||||||||||
Due in one year or less |
$ | $ | $ | $ | ||||||||||||
Due after one year through five years |
||||||||||||||||
Due after five years through ten years |
||||||||||||||||
Due after ten years |
||||||||||||||||
$ | $ | $ | $ | |||||||||||||
Weighted average contractual maturity |
6. |
Acquisitions, Goodwill and Other Intangible Assets |
December 31, 2020 |
December 31, 2019 |
|||||||||||||||||||||||
Gross Carrying Amount |
Accumulated Amortization |
Net Book Value |
Gross Carrying Amount |
Accumulated Amortization |
Net Book Value |
|||||||||||||||||||
Goodwill and intangible assets: |
||||||||||||||||||||||||
Goodwill |
$ | $ | — | $ | $ | $ | — | $ | ||||||||||||||||
Intangible assets (1) |
( |
) | ( |
) | ||||||||||||||||||||
$ | $ | ( |
) | $ | $ | $ | ( |
) | $ | |||||||||||||||
(1) |
Total weighted average amortization period was |
Years Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Beginning balance |
$ | $ | ||||||
Additions from acquisitions |
||||||||
Impairment losses |
||||||||
Ending balance |
$ | $ | ||||||
Year Ended December 31, |
||||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
$ | ||||
7. |
Selected Balance Sheet Data |
Advances and Loans |
Commissions Receivable |
Total |
||||||||||
Beginning balance as of January 1, 2020 |
$ | $ | (1) |
$ | ||||||||
Credit loss expense |
||||||||||||
Write-offs |
( |
) | ( |
) | ||||||||
Ending balance as of December 31, 2020 |
$ | $ | $ | |||||||||
(1) |
Includes cumulative-effect adjustment related to the adoption of ASU 2016-13. |
Advances and Loans |
Commissions Receivable |
Total |
||||||||||
Beginning balance as of January 1, 2019 |
$ | $ | |
$ | ||||||||
Credit loss expense |
||||||||||||
Write-offs |
( |
) | ( |
) | ||||||||
Ending balance as of December 31, 2019 |
$ | $ | $ | |||||||||
Current December 31, |
Non-Current December 31, |
|||||||||||||||
2020 |
2019 |
2020 |
2019 |
|||||||||||||
MSRs, net of amortization |
$ | $ | $ | $ | ||||||||||||
Security deposits |
||||||||||||||||
Employee notes receivable (1) |
||||||||||||||||
Customer trust accounts and other |
||||||||||||||||
$ | $ | $ | $ | |||||||||||||
(1) |
Reduction of accrued bonuses and other employee related expenses in settlement of employee notes receivable were $ a nd $ |
December 31, |
||||||||
2020 |
2019 |
|||||||
Beginning balance |
$ | $ | ||||||
Additions |
||||||||
Amortization |
( |
) | ( |
) | ||||
Ending balance |
$ | $ | ||||||
Current December 31, |
Non-Current December 31, |
|||||||||||||||
2020 |
2019 |
2020 |
2019 |
|||||||||||||
SARs liability (1) |
$ | $ | $ | $ | ||||||||||||
Commissions payable to investment sales and financing professionals |
||||||||||||||||
Deferred compensation liability (1) |
||||||||||||||||
Other |
||||||||||||||||
$ | $ | $ | $ | |||||||||||||
(1) |
The SARs and deferred compensation liability become subject to payout as a result of a participant no longer being considered as a service provider. As a result of the retirement of certain participants, estimated amounts to be paid to the participants within the next twelve months have been classified as current. |
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Increase (decrease) in the carrying value of the assets held in the rabbi trust (1) |
$ | $ | $ | ( |
) | |||||||
|
|
|
|
|
|
|||||||
Increase (decrease) in the net carrying value of the deferred compensation obligation (2) |
$ | $ | $ | ( |
) | |||||||
|
|
|
|
|
|
(1) |
Recorded in other income (expense), net in the consolidated statements of net and comprehensive income. |
(2) |
Recorded in selling, general and administrative expense in the consolidated statements of net and comprehensive income. |
Non-Current |
||||||||
December 31, |
||||||||
2020 |
2019 |
|||||||
Deferred consideration (1)(2) |
$ | $ | ||||||
Contingent consideration (1)(2) |
||||||||
Other |
||||||||
|
|
|
|
|||||
$ | $ | |||||||
|
|
|
|
(1) |
The current portions of deferred consideration in the amounts of $ |
(2) |
Deferred consideration in the aggregate amount of $ non-current portions, respectively. |
8. |
Notes Payable to Former Stockholders |
9. |
Related-Party Transactions |
10. |
Fair Value Measurements |
December 31, 2020 |
December 31, 2019 |
|||||||||||||||||||||||||||||||
Fair Value |
Level 1 |
Level 2 |
Level 3 |
Fair Value |
Level 1 |
Level 2 |
Level 3 |
|||||||||||||||||||||||||
Assets: |
||||||||||||||||||||||||||||||||
Assets held in rabbi trust |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Cash equivalents (1) : |
||||||||||||||||||||||||||||||||
Commercial paper |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Money market funds |
||||||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
Marketable debt securities, available-for-sale: |
||||||||||||||||||||||||||||||||
Short-term investments: |
||||||||||||||||||||||||||||||||
U.S. treasuries |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
U.S. government sponsored entities |
||||||||||||||||||||||||||||||||
Corporate debt |
||||||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
Long-term investments: |
||||||||||||||||||||||||||||||||
U.S. treasuries |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
U.S. government sponsored entities |
||||||||||||||||||||||||||||||||
Corporate debt |
||||||||||||||||||||||||||||||||
ABS and other |
||||||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
Liabilities: |
||||||||||||||||||||||||||||||||
Contingent consideration |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Deferred consideration |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Deferred compensation liability |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
(1) |
Included in cash and cash equivalents on the accompanying consolidated balance sheets. |
December 31, |
||||||||
2020 |
2019 |
|||||||
Beginning balance (1) |
$ | $ | ||||||
Contingent consideration in connection with acquisitions (2) |
||||||||
Change in fair value of contingent consideration |
||||||||
Payments of contingent consideration |
( |
) | ( |
) | ||||
Ending balance |
$ | $ | ||||||
(1) |
Beginning balance for 2020 reflects the reclassification of $ |
(2) |
Contingent consideration in connections with acquisitions represents a noncash investing activity. |
Fair Value at December 31, 2020 |
Valuation Technique |
Unobservable inputs |
Range (Weighted Average) (1) |
|||||||||||||||||
Contingent consideration |
$ | Discounted cash flow | Expected life of cash flows | ( |
) | |||||||||||||||
Discount rate | ( |
) | ||||||||||||||||||
Probability of achievement | ( |
) | ||||||||||||||||||
Fair Value at December 31, 2019 |
Valuation Technique |
Unobservable inputs |
Range (Weighted Average) (1) |
|||||||||||||||||
Contingent consideration |
$ | Discounted cash flow | Expected life of cash flows | ( |
) | |||||||||||||||
Discount rate | ( |
) | ||||||||||||||||||
Probability of achievement | ( |
) |
(1) |
Unobservable inputs were weighted by the relative fair value of the instruments. |
Fair Value at December 31, 2020 |
Valuation Technique |
Unobservable inputs |
Range (1) | |||||||
MSRs |
$ | Discounted cash flow | Constant prepayment rates | |||||||
Constant default rate | ||||||||||
Loss severity | ||||||||||
Discount rate | ||||||||||
Fair Value at December 31, 2019 |
Valuation Technique |
Unobservable inputs |
Range (1) | |||||||
MSRs |
$ | Discounted cash flow | Constant prepayment rates | |||||||
Constant default rate | ||||||||||
Loss severity | ||||||||||
Discount rate |
(1) |
Weighted average is based on the % constant prepayment rate scenario which the Company uses as the reported fair value. |
11. |
Stockholders’ Equity |
12. |
Stock-Based Compensation Plans |
RSA Grants to Non-employee Directors |
RSU Grants to Employees |
RSU Grants to Independent Contractors |
Total |
Weighted- Average Grant Date Fair Value Per Share |
||||||||||||||||
Nonvested shares at December 31, 2017 (1) |
$ | |||||||||||||||||||
Granted |
||||||||||||||||||||
Vested |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Transferred |
( |
) | ||||||||||||||||||
Forfeited/canceled |
( |
) | ( |
) | ( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Nonvested shares at December 31, 2018 (1) |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Granted |
||||||||||||||||||||
Vested |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Transferred |
( |
) | ||||||||||||||||||
Forfeited/canceled |
( |
) | ( |
) | ( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Nonvested shares at December 31, 2019 (1) |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Granted |
||||||||||||||||||||
Vested |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Transferred |
( |
) | ||||||||||||||||||
Forfeited/canceled |
( |
) | ( |
) | ( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Nonvested shares at December 31, 2020 (1) |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Unrecognized stock-based compensation expense as of December 31, 2020 (2) |
$ | $ | $ | $ | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Weighted average remaining vesting period (years) as of December 31, 2020 |
||||||||||||||||||||
|
|
|
|
|
|
|
|
(1) |
Nonvested RSUs will be settled through the issuance of new shares of common stock. |
(2) |
The total unrecognized compensation expense is expected to be recognized over a weighted-average period of approximately |
December 31, 2020 |
||||
2021 |
||||
2022 |
||||
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
ESPP |
$ | $ | $ | |||||||||
RSAs – non-employee directors |
||||||||||||
RSUs – employees (1) |
||||||||||||
RSUs – independent contractors (2) |
||||||||||||
$ | $ | $ | ||||||||||
(1) |
Includes expense related to the acceleration of vesting of certain RSUs. |
(2) |
The Company grants RSUs to independent contractors (i.e. investment sales and financing professionals), who are considered non-employees. Prior to the adoption of ASU No. 2018-07 on July 1, 2018, such awards were required to be measured at fair value at the end of each reporting period until settlement. Stock-based compensation expense was therefore impacted by the changes in the Company’s common stock price during each reporting period prior to the adoption. New awards after the date of adoption are measured based on the grant date closing price of the Company’s common stock consistent with awards made to the Company’s employees and non-employee directors. |
13. |
Income Taxes |
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
United States |
$ | $ | $ | |||||||||
Foreign |
( |
) | ( |
) | ( |
) | ||||||
$ | $ | $ | ||||||||||
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Federal: |
||||||||||||
Current |
$ | $ | $ | |||||||||
Deferred |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|||||||
State: |
||||||||||||
Current |
||||||||||||
Deferred |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|||||||
Foreign: |
||||||||||||
Current |
||||||||||||
Deferred |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
( |
) | |||||||||||
|
|
|
|
|
|
|||||||
$ | $ | $ | ||||||||||
|
|
|
|
|
|
December 31, |
||||||||
2020 |
2019 |
|||||||
Deferred Tax Assets: |
||||||||
Accrued expenses and bonuses |
$ | $ | ||||||
Bad debt and other reserves |
||||||||
Deferred compensation |
||||||||
Operating lease ROU assets, net |
||||||||
Stock-based compensation |
||||||||
Net operating and capital loss carryforwards |
||||||||
State taxes |
( |
) | ||||||
Amortizable intangibles and other |
||||||||
|
|
|
|
|||||
Deferred tax assets before valuation allowance |
||||||||
Valuation allowance |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Deferred Tax Assets |
||||||||
|
|
|
|
|||||
Deferred Tax Liabilities: |
||||||||
Fixed assets |
( |
) | ( |
) | ||||
Operating lease liabilities |
( |
) | ( |
) | ||||
Prepaid expenses |
( |
) | ( |
) | ||||
Other comprehensive income |
( |
) | ( |
) | ||||
Goodwill and other |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Deferred Tax Liabilities |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Deferred Tax Assets, Net |
$ | $ | ||||||
|
|
|
|
Years Ended December 31, |
||||||||||||||||||||||||
2020 |
2019 |
2018 |
||||||||||||||||||||||
Amount |
Rate |
Amount |
Rate |
Amount |
Rate |
|||||||||||||||||||
Income tax expense at the federal statutory rate |
$ | % | $ | % | $ | % | ||||||||||||||||||
State income tax expense, net of federal benefit |
% | % | % | |||||||||||||||||||||
Windfall tax benefits, net related to stock-based compensation |
% | ( |
) | ( |
)% | ( |
) | ( |
)% | |||||||||||||||
Change in valuation allowance |
% | % | % | |||||||||||||||||||||
Permanent and other items (1) |
% | % | % | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$ | % | $ | % | $ | % | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Permanent items relate principally to compensation charges, qualified transportation fringe benefits, reversal of uncertain tax positions and meals and entertainment. |
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Beginning balance |
$ | $ | $ | |||||||||
Gross increase (decrease) as a result of positions taken: |
||||||||||||
Prior periods |
||||||||||||
Current period |
||||||||||||
Settlement with tax authorities |
||||||||||||
Expiration of applicable statutes of limitation |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Ending balance |
$ | $ | $ | |||||||||
|
|
|
|
|
|
14. |
Retirement Plans |
15. |
Earnings per Share |
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Numerator (Basic and Diluted): |
||||||||||||
Net income |
$ | $ | $ | |||||||||
Increase in value for stock settled consideration, net |
||||||||||||
Adjusted net income |
$ | $ | $ | |||||||||
Denominator: |
||||||||||||
Basic |
||||||||||||
Weighted Average Common Shares Issued and Outstanding |
||||||||||||
Deduct: Unvested RSAs (1) |
( |
) | ( |
) | ( |
) | ||||||
Add: Fully vested DSUs (2) |
||||||||||||
Weighted Average Common Shares Outstanding |
||||||||||||
Basic earnings per common share |
$ | $ | $ | |||||||||
Diluted |
||||||||||||
Weighted Average Common Shares Outstanding from above |
||||||||||||
Add: Dilutive effect of RSUs, RSAs & ESPP |
||||||||||||
Add: Contingently issuable shares (3) |
||||||||||||
Weighted Average Common Shares Outstanding |
||||||||||||
Diluted earnings per common share |
$ | $ | $ | |||||||||
Antidilutive shares excluded from diluted earnings per common share (4) |
||||||||||||
(1) |
RSAs were issued and outstanding to the non-employee directors and generally have a vesting term subject to service requirements. See Note 12 – “Stock-Based Compensation Plans” for additional information. -year |
(2) |
Shares are included in weighted average common shares outstanding as the shares are fully vested but have not yet been delivered. See Note 12 – “Stock-Based Compensation Plans” for additional information. |
(3) |
Relates to contingently issuable stock settled consideration. |
(4) |
Primarily pertaining to RSU grants to the Company’s employees and independent contractors. |
16. |
Commitments and Contingencies |
17. |
Selected Quarterly Financial Data (Unaudited) |
Three Months Ended |
||||||||||||||||||||||||||||||||
Dec. 31 |
Sep. 30 |
Jun. 30 |
Mar. 31 |
Dec. 31 |
Sep. 30 |
Jun. 30 |
Mar. 31 |
|||||||||||||||||||||||||
2020 |
2020 |
2020 |
2020 |
2019 |
2019 |
2019 |
2019 |
|||||||||||||||||||||||||
Consolidated Financial Statement Data: |
(in thousands, except per share data) |
|||||||||||||||||||||||||||||||
Total revenues |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Cost of services |
||||||||||||||||||||||||||||||||
Operating income (loss) |
( |
) | ||||||||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||||||
Earnings per share: |
||||||||||||||||||||||||||||||||
Basic |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Diluted |
$ | $ | $ | $ | $ | $ | $ | $ |